Angina Clinical Trial
Official title:
Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions
Nasal oxygen is widely used as pain relief against ischemic pain during Percutaneous Coronary Intervention (PCI). However, to our knowledge no randomised clinical trials have tested this. In contrast, oxygen causes coronary artery vasoconstriction in man. Furthermore, a recent Cochrane meta-analysis has shown no evidence of beneficial effect of oxygen for patients with acute myocardial infarction (with normal blood saturation. The investigators therefore wanted to examine if oxygen reduces ischemic pain during PCI for stable angina or NSTEMI.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
| Withdrawn |
NCT03134105 -
A Wearable EducAtional Intervention to REduce Angina
|
N/A | |
| Completed |
NCT02832115 -
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
|
Phase 4 | |
| Completed |
NCT02265796 -
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
|
Phase 2 | |
| Terminated |
NCT00221182 -
Stem Cell Study for Patients With Heart Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT01721096 -
XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
|
||
| Recruiting |
NCT01214499 -
Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina
|
Phase 2 | |
| Terminated |
NCT01285297 -
Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction
|
N/A | |
| Withdrawn |
NCT00774891 -
Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
|
N/A | |
| Completed |
NCT02707783 -
Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
|
||
| Completed |
NCT02065102 -
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
|
N/A | |
| Completed |
NCT00946725 -
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
|
Phase 1 | |
| Recruiting |
NCT02439541 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
| Withdrawn |
NCT00657514 -
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
|
Phase 4 | |
| Recruiting |
NCT01361659 -
Shockwave Treatment for Advanced Angina in Maastricht
|
N/A | |
| Recruiting |
NCT05786417 -
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
|
Phase 4 | |
| Withdrawn |
NCT02507050 -
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
|
Phase 4 | |
| Active, not recruiting |
NCT02468960 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)
|
N/A | |
| Completed |
NCT01086228 -
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
|
N/A |